Nanoplatforms for cancer theranostics
Nanoplatforms for cancer theranostics is a research topic within Biomedical Engineering. Science Explorer counts 50k research works in it since 1952. 29.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the use of nanotechnology, reactive oxygen species, and advanced imaging techniques for targeted cancer therapy and diagnosis. It covers a wide range of topics including photothermal therapy, fluorescence imaging, nanoparticle-based drug delivery, and the development of theranostic agents for combined imaging and therapy. The research also delves into the potential of immunotherapy and the use of biomimetic nanoparticles for enhanced cancer treatment.
- Nanoparticles
- Photothermal Therapy
- Reactive Oxygen Species
- Fluorescence Imaging
- Photodynamic Therapy
- Near-Infrared
- Tumor Targeting
- Immunotherapy
- Biomimetic Nanoparticles
- Theranostic Agents
- Research works
- 50k fractional, since 1952
- In the world top 10%
- 15k per year above
- Top-10% rate
- 29.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +104% the tick is no change
Which countries lead Nanoplatforms for cancer theranostics research?
By volume, China and the United States publish the most (10k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 China 10k works
- 2 United States 1.7k works
- 3 India 1k works
- 4 South Korea 510 works
- 5 Iran 385 works
- 6 Japan 340 works
- 7 ?? 278 works
- 8 Russia 278 works
- 9 Germany 263 works
- 10 France 261 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Nanoplatforms for cancer theranostics research?
By volume in 2022–2025, Chinese Academy of Sciences publishes the most Nanoplatforms for cancer theranostics research, followed by Sichuan University and Shanghai Jiao Tong University.
By volume, 2022–2025
- 1 Chinese Academy of SciencesChina 193 works
- 2 Sichuan UniversityChina 170 works
- 3 Shanghai Jiao Tong UniversityChina 136 works
- 4 Sun Yat-sen UniversityChina 125 works
- 5 Soochow UniversityChina 122 works
- 6 Zhejiang UniversityChina 104 works
- 7 University of Chinese Academy of SciencesChina 99 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 98 works
- 9 Jilin UniversityChina 95 works
- 10 Fudan UniversityChina 94 works
Who are the leading researchers in Nanoplatforms for cancer theranostics?
The most-cited researchers publishing on Nanoplatforms for cancer theranostics include Ben Zhong Tang, Hua Zhang and Wei Huang.
- 1 Ben Zhong Tang Hong Kong 7k citations
- 2 Hua Zhang Singapore 5.9k citations
- 3 Wei Huang China 5.5k citations
- 4 Dirk Schadendorf Germany 4.4k citations
- 5 Moungi G. Bawendi United States 4.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Nanoplatforms for cancer theranostics research done?
The largest centres of Nanoplatforms for cancer theranostics research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Tianjin, Nanjing and Chengdu.
Largest cities, 2022–2025
Where it is the local speciality
- Tianjin21.1 works35×
- Nanjing30.6 works15×
- Chengdu35.3 works11×
- XuzhouCN · 53.7 works9.0×
Location quotient: how much more of its research is in Nanoplatforms for cancer theranostics than the world average.
Where is the best place to study Nanoplatforms for cancer theranostics?
Among universities, judged by research, Soochow University, Southern Medical University and Chinese University of Hong Kong, Shenzhen score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Soochow UniversityChina | 77.0 | 44.5% | 8.7× | 122 | +219.5% |
| 2 | Southern Medical UniversityChina | 75.6 | 41.6% | 12.4× | 78 | +275.5% |
| 3 | Chinese University of Hong Kong, ShenzhenChina | 72.2 | 50.5% | 13.5× | 44 | — |
| 4 | Shenyang Pharmaceutical UniversityChina | 71.2 | 35.5% | 33.8× | 78 | +511.5% |
| 5 | Wenzhou Medical UniversityChina | 70.3 | 42.1% | 9.0× | 54 | +501.9% |
| 6 | China Pharmaceutical UniversityChina | 70.2 | 30.7% | 24.4× | 91 | +237.6% |
| 7 | Beijing University of Chemical TechnologyChina | 68.8 | 38.8% | 8.5× | 65 | +362.9% |
| 8 | Sichuan UniversityChina | 68.7 | 40.3% | 5.7× | 170 | +422.3% |
| 9 | Nanyang Technological UniversitySingapore | 67.9 | 56.2% | 3.0× | 43 | +333.6% |
| 10 | Anhui Medical UniversityChina | 67.2 | 37.4% | 9.1× | 47 | +252.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Nanoplatforms for cancer theranostics research growing?
Output in 2018–2022 was 104% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Nanoplatforms for cancer theranostics.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.